Four weeks later, the mice were sacrificed, and the results demonstrated that GC ablation significantly enhanced tumor sensitivity to gemcitabine, evidenced by reduced tumor volume and Ki67 expression (Figure S8B,C, Supporting Information). Here, MKI67 is linked to neoplasm.